8-K
filed May 29, 2026, 5:01 PM ET
ticker TPST
CIK 0001544227
leadership
confidence high
sentiment neutral
materiality 0.40
Tempest Therapeutics director Simantov resigns from Board effective May 23, 2026
Tempest Therapeutics, Inc.
- Ms. Simantov resigned from the Board; no disagreement with company operations or policies.
- Separation Agreement waives all accrued and unpaid retainer fees from director compensation program.
- Her outstanding stock option awards and share ownership are unaffected; indemnification agreement continues for six years.
- Full text of Separation Agreement will be filed with the Company's Q2 2026 10-Q.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-248648
- form_type
- 8-K
- ticker
- TPST
- cik
- 0001544227
- company_name
- Tempest Therapeutics, Inc.
- filed_at
- 2026-05-29T21:01:10+00:00
- discovered_at
- 2026-05-29T21:02:00.275367+00:00
- generated_at
- 2026-05-29T21:02:25.402730+00:00
- sec_items
- ["5.02"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-248648
- json_url
- https://secwatch.observer/filing/0001193125-26-248648.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-248648.md
- text_url
- https://secwatch.observer/filing/0001193125-26-248648.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1544227/000119312526248648/0001193125-26-248648-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1544227/000119312526248648/d220128d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
Federal Home Loan Bank of Pittsburgh
FHLB Pittsburgh CFO Edward V. Weller to retire on Oct 20, 2026
Federal Home Loan Bank of Pittsburgh
June 1, 2026, 3:08 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
On May 28, 2026, the Federal Home Loan Bank of Pittsburgh (Bank) received notice from Edward V. Weller, Chief Financial Officer, of his intent to retire from the Bank on or about October 20, 2026.
Filing page
SEC filing
FSBW
FS Bancorp names Matt Mullet CEO as planned; Joe Adams retires but stays on board
FS Bancorp, Inc.
June 1, 2026, 11:31 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026
Filing page
SEC filing
MED
Medifast Chief Legal Officer resigns; receives one-month severance of $35,648
MEDIFAST INC
June 1, 2026, 8:59 AM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
Effective as of May 29, 2026, Jason L. Groves, Esq., the Chief Legal Officer & Corporate Secretary of Medifast, Inc. (the “Company”), tendered his resignation from the Company.
Filing page
SEC filing
DY
Dycom board reduced to nine; two directors retire after annual meeting
DYCOM INDUSTRIES INC
June 1, 2026, 8:04 AM ET
leadership
Items 5.02, 5.07
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
Ms. Laurie J. Thomsen did not stand for election at the 2026 Annual Meeting of Shareholders held on May 28, 2026 (the “2026 Annual Meeting”) and retired from the Board effective at the conclusion of the 2026 Annual Meeting.
Filing page
SEC filing
CG
Carlyle appoints Kate Heinzelman as General Counsel; Jeff Ferguson to be Senior Advisor
Carlyle Group Inc.
June 1, 2026, 8:00 AM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
Mr. Ferguson will become a Senior Advisor to Carlyle
Filing page
SEC filing
SKY
Champion Homes Chair Tawn Kelley resigns; Michael Berman appointed new Chair
Champion Homes, Inc.
June 1, 2026, 6:50 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
On May 31, 2026, Tawn Kelley resigned as Chair and a member of the Board of Directors (the “Board”) of Champion Homes, Inc. (the “Company”), effective immediately.
Filing page
SEC filing
SAIC
SAIC EVP Civilian Business Group Attili steps down amid internal reorganization
Science Applications International Corp
June 1, 2026, 6:45 AM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
On June 1, 2026, Science Applications International Corporation (the “Company”) announced that in connection with an internal reorganization, Srinivas Attili, Executive Vice President, Civilian Business Group, stepped down from his role effective May 29, 2026 and will depart from the Company on or about June 12, 2026.
Filing page
SEC filing
VG
Venture Global CCO Thomas Earl steps down; to remain non-executive employee for one year
Venture Global, Inc.
May 29, 2026, 6:30 PM ET
leadership
Items 5.02
same fact type: executive_change
same SEC item: 5.02
same event type: leadership
similar materiality
This filing
On May 23, 2026, Ms. Simantov notified Tempest Therapeutics, Inc. (the "Company") of her resignation from the Board of Directors of the Company (the "Board"), effective as of such date.
Comparable filing
On May 27, 2026, Thomas Earl, the Chief Commercial Officer of VG LNG Marketing, LLC (UK Branch) (the “Company”), an indirect wholly-owned subsidiary of Venture Global, Inc., notified the Company that he will be stepping down from his position with the Company, effective June 1, 2026, after which Mr. Earl will remain an employee of the Company in a non-executive capacity for a term of one year.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.